Rushad Patell
Overview
Explore the profile of Rushad Patell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
1153
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Lam B, Zerbey S, Pinson A, Robertson W, Rosovsky R, Lake L, et al.
Res Pract Thromb Haemost
. 2024 Jan;
7(8):102272.
PMID: 38169996
No abstract available.
22.
Simon S, Patell R, Zwicker J, Kazi D, Hollenbeck B
JAMA Netw Open
. 2023 Dec;
6(12):e2345883.
PMID: 38039005
Importance: The optimal pharmacologic thromboprophylaxis agent after total hip and total knee arthroplasty is uncertain and consensus is lacking. Quantifying the risk of postoperative venous thromboembolism (VTE) and bleeding and...
23.
Iyengar V, Agrawal S, Chiasakul T, Tehranchi K, McNichol M, Carney B, et al.
J Thromb Haemost
. 2023 Oct;
22(2):423-429.
PMID: 37866517
Background: The safety and efficacy of direct-acting oral anticoagulants (DOACs) for therapeutic anticoagulation in the setting of primary or metastatic brain cancer is not known. Objectives: To conduct a meta-analysis...
24.
Patell R, Hsu C, Shi M, Grosso M, Duggal A, Buller H, et al.
Haematologica
. 2023 Oct;
109(6):1849-1856.
PMID: 37855029
Thrombocytopenia occurs frequently in patients with cancer-associated thrombosis (CAT), however prospective evaluation of clinical outcomes following randomization to anticoagulants is limited. The HOKUSAI VTE Cancer study was a randomized, open-label,...
25.
Chiasakul T, Lam B, McNichol M, Robertson W, Rosovsky R, Lake L, et al.
Eur J Haematol
. 2023 Oct;
111(6):951-962.
PMID: 37794526
Background: Accurate diagnostic and prognostic predictions of venous thromboembolism (VTE) are crucial for VTE management. Artificial intelligence (AI) enables autonomous identification of the most predictive patterns from large complex data....
26.
Lam B, Dodge L, Datta S, Rosovsky R, Robertson W, Lake L, et al.
Res Pract Thromb Haemost
. 2023 Sep;
7(6):102168.
PMID: 37767063
Background: Venous thromboembolism (VTE) is a leading cause of preventable mortality among hospitalized patients, but appropriate risk assessment and thromboprophylaxis remain underutilized or misapplied. Objectives: We conducted an electronic survey...
27.
Iyengar V, Patell R, Ren S, Ma S, Pinson A, Barnett A, et al.
Blood Adv
. 2023 Sep;
7(24):7516-7524.
PMID: 37756539
Whether thrombocytopenia substantively increases the risk of hemorrhage associated with anticoagulation in patients with atrial fibrillation (AF) is not established. The purpose of this study was to compare rates of...
28.
Andersen Jr M, Bindal P, Michaels P, Elavalakanar P, Liegel J, Dias A, et al.
Ann Hematol
. 2023 Sep;
102(12):3643-3645.
PMID: 37749320
No abstract available.
29.
Muse O, Patell R, Peters C, Yang M, El-Darzi E, Schulman S, et al.
JCI Insight
. 2023 Aug;
8(19).
PMID: 37651191
Thrombosis is a common complication of advanced cancer, yet the cellular mechanisms linking malignancy to thrombosis are poorly understood. The unfolded protein response (UPR) is an ER stress response associated...
30.
Ma S, Patell R, Miller E, Ren S, Marquez-Garcia J, Panoff S, et al.
J Thromb Haemost
. 2023 Feb;
21(5):1148-1155.
PMID: 36740041
Background: Spontaneous intracranial hemorrhage (ICH) is a frequent and severe consequence of primary brain tumors. The safety of antiplatelet medications in this patient population is undefined. Objective: The primary objective...